American Healthcare REIT Inc

AHR remains in a Stage 2 advancing uptrend supported by a Parabola pattern, but extreme overbought readings and visible exhaustion candles discourage chasing the recent extension. The medium-term bias stays bullish, so we recommend deferring buys until pullbacks into the rising 9 and 21 EMA support zone are accepted rather than immediately deploying capital at current levels.

• ↑Normalized FFO up 31.6% YoY to $0.50/share in Q1 2026
• ↑Same-store NOI grew 12.1% for ninth straight quarter of double-digit gains
• ↓Negative earnings yield and weak book-to-price suggest overvaluation